RxDoctor Payments Data

Paige Reed

Psychiatric/Mental Health · Newton, IANPI 1417679168

Payments from drug & device makers

$3,903in general payments, 2019–2025

Across 233 payments — averaging $16.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$644
  • Otsuka America Pharmaceutical, Inc.$452
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$452
  • Alkermes, Inc.$397
  • Johnson & Johnson$394
  • Lundbeck LLC$316
  • plus $1K from 15 others

What the payments were for

  • Food & beverage$3,82298%
  • Education$812%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,903 in reported general payments places this provider in the 85th percentile of 443 psychiatric/mental health providers in Iowa.

See all psychiatric/mental health providers in Iowa

Medicare billing

Part B allowed, 2024
$10,778
Medicare patients
27
Services billed
200

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl60$85,962
Invega SustennaPaliperidone Palmitate25$61,806
RexultiBrexpiprazole27$49,567
Loreev XrLorazepam15$6,302
VyvanseLisdexamfetamine Dimesylate14$5,245
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine39$1,461
Bupropion XlBupropion Hcl107$1,270
Quetiapine Fumarate87$1,168
Duloxetine Hcl85$1,105
Aripiprazole57$828
Hydroxyzine Pamoate47$813
Zolpidem Tartrate ErZolpidem Tartrate15$808
Sertraline Hcl89$601
Clonazepam90$585
Lorazepam81$540

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$644$85,96260 claims
Johnson & JohnsonInvega Sustenna$394$61,80625 claims
Otsuka America Pharmaceutical, Inc.Rexulti$452$49,56727 claims
Almatica Pharma LLCLoreev Xr, Sertraline Hcl$104$6,903104 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$65$5,24514 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 443 psychiatric/mental health providers in Iowa.

Other psychiatric/mental health in Newton

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →